Dermatologicals in Norway
Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively inelastic despite significant unit price increases at a time of high inflation. Dermatologicals remains the third largest OTC consumer health category in Norway after cough, cold, allergy (hay fever) remedies and analgesics. The steady demand for dematol...
Euromonitor International's Dermatologicals in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Dermatologicals in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Dermatologicals market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN NORWAY
KEY DATA FINDINGS
2023 DEVELOPMENTS
Positive sales growth for dermatologicals as demand for core products remains inelastic
Antiparasitics/lice (head and body) treatments rebounds from previous sales slump
Stable growth for antipruritics, the most popular category of dermatologicals in Norway
PROSPECTS AND OPPORTUNITIES
Reduced stigma surrounding the use of dermatologicals set to spur demand
Sales set to receive a boost from consumers spending more time outdoors
The rise of premium beauty and personal care products that mimic dermatologicals
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 6 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN NORWAY
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2018-2023
Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format: % Value 2018-2023
Table 16 Distribution of Consumer Health by Format and Category: % Value 2023
Table 17 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
KEY DATA FINDINGS
2023 DEVELOPMENTS
Positive sales growth for dermatologicals as demand for core products remains inelastic
Antiparasitics/lice (head and body) treatments rebounds from previous sales slump
Stable growth for antipruritics, the most popular category of dermatologicals in Norway
PROSPECTS AND OPPORTUNITIES
Reduced stigma surrounding the use of dermatologicals set to spur demand
Sales set to receive a boost from consumers spending more time outdoors
The rise of premium beauty and personal care products that mimic dermatologicals
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 6 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN NORWAY
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2018-2023
Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format: % Value 2018-2023
Table 16 Distribution of Consumer Health by Format and Category: % Value 2023
Table 17 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
